NCT00372333View on ClinicalTrials.gov

IDEA-033 Open Label Study

PHASE3CompletedINTERVENTIONAL

Enrollment

491

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

December 31, 2007

Study Completion Date

April 30, 2008

Conditions

Joint PainMusculoskeletal PainStiffnessSoft Tissue Inflammation in Designated Target Area(s)

Interventions

DRUG

IDEA-033

Trial Locations (1)

82166

X-pert med GmbH / Ilka Rother, Gräfelfing

Sponsors

Lead Sponsor

All Listed Sponsors

lead

IDEA AG

INDUSTRY

NCT00372333 - IDEA-033 Open Label Study | Biotech Hunter | Biotech Hunter